Krystal Biotech

Traded on the St. Petersburg Stock Exchange
Krystal Biotech is an American gene therapy company, develops and commercializes medicines for patients suffering from skin diseases. Krystal Biotech was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Krystal Biotech stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Krystal Biotech balance sheet

Report period2018 2019 2020 2021 2022 Q2 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Krystal Biotech cash flows

Report period2018 2019 2020 2021 2022 Q2 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Krystal Biotech multipliers

Report period2018 2019 2020 2021 2022 Q2 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Krystal Biotech profitability

Report period2018 2019 2020 2021 2022 Q2 23 TTM
ROA
ROE
ROS
Krystal Biotech assets
Krystal Biotech cash flows

Krystal Biotech dividend policy

The company doesn't provide dividend

Krystal Biotech shares

TickerNameTypeNominal valueISINPrice
KRYS:USKrystal BiotechCommon share-US5011471027$170.7
Krystal Biotech news
10.05.2022
Krystal Biotech's GAAP loss for 3 months of 2022 was $49.965 million, up 3.2 times from $15.812 million in the previous year.
Source: {source} pictogram ir.krystalbio.com
Pictogram next
28.02.2022
Krystal Biotech's GAAP loss for 2021 was $69.57 million, up 2.2 times from $32.167 million in the previous year.
Source: {source} pictogram ir.krystalbio.com
Pictogram next
08.11.2021
Krystal Biotech's GAAP loss for 9M 2021 was $47.764 million, up 2.2 times from $21.784 million in the previous year.
Source: {source} pictogram ir.krystalbio.com
Pictogram next
09.08.2021
Krystal Biotech's GAAP loss for 6M 2021 was $32.174 million, up 2.6x% from $12.174 million in the prior year
Source: {source} pictogram ir.krystalbio.com
Pictogram next
All Krystal Biotech news
General information
Company nameKrystal Biotech
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address2100 Wharton Street Suite 701 Pittsburgh, PA 15203 United States
Mailing address2100 Wharton Street Suite 701 Pittsburgh, PA 15203 United States
Websiteir.krystalbio.com
Information disclosurewww.sec.gov